Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine

Pain Relief by Targeting Nonrestorative Sleep in Fibromyalgia

This Phase 3 randomized trial examines the role of nonrestorative sleep in fibromyalgia and investigates a bedtime sublingual formulation of cyclobenzaprine as a potential approach to addressing sleep-related symptoms. By focusing on sleep physiology rather than pain alone, the study contributes to ongoing research into the underlying mechanisms of fibromyalgia and emerging treatment strategies.

FAC shares this research in lay language to support informed conversations and encourage members to explore current evidence in fibromyalgia care.

This is a Lay Summary on Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine. We have the English Fibromyalgia Association Canada banner with the title om the left and someone inserting a pill under their tongue on the left (sublingual)

Pain Relief by Targeting Nonrestorative Sleep in Fibromyalgia

This Phase 3 randomized trial examines the role of nonrestorative sleep in fibromyalgia and investigates a bedtime sublingual formulation of cyclobenzaprine as a potential approach to addressing sleep-related symptoms. By focusing on sleep physiology rather than pain alone, the study contributes to ongoing research into the underlying mechanisms of fibromyalgia and emerging treatment strategies.

FAC shares this research in lay language to support informed conversations and encourage members to explore current evidence in fibromyalgia care.

This content requires membership to view.
Please Join Now or sign in below.
Already a member? Log in here
en_CAEN
fr_CAFR en_CAEN